Shangguan D - Search Results

1

Single-Cell Profiling to Explore Immunological Heterogeneity of Tumor Microenvironment in Breast Cancer.

Yuan X, Wang J, Huang Y, Shangguan D, Zhang P. Yuan X, et al. Among authors: shangguan d. Front Immunol. 2021 Feb 25;12:643692. doi: 10.3389/fimmu.2021.643692. eCollection 2021. Front Immunol. 2021. PMID: 33717201 Free PMC article. Review.

2

Changes of tumor microenvironment in non-small cell lung cancer after TKI treatments.

Chen S, Tang J, Liu F, Li W, Yan T, Shangguan D, Yang N, Liao D. Chen S, et al. Among authors: shangguan d. Front Immunol. 2023 Mar 6;14:1094764. doi: 10.3389/fimmu.2023.1094764. eCollection 2023. Front Immunol. 2023. PMID: 36949948 Free PMC article. Review.

3

Therapeutic Drug Monitoring of Targeted Therapy in Metastatic Renal Cell Carcinoma.

Liao D, Shangguan D, Yao D, Zhu Q, Cao L, Long M, Wu Y, Xiang D, Yang N. Liao D, et al. Among authors: shangguan d. Protein Pept Lett. 2018;25(6):528-533. doi: 10.2174/0929866525666180531073959. Protein Pept Lett. 2018. PMID: 29848258 Review.

4

Recent Advancements of Monotherapy, Combination, and Sequential Treatment of EGFR/ALK-TKIs and ICIs in Non-Small Cell Lung Cancer.

Liao D, Yu L, Shangguan D, Zhang Y, Xiao B, Liu N, Yang N. Liao D, et al. Among authors: shangguan d. Front Pharmacol. 2022 Jun 6;13:905947. doi: 10.3389/fphar.2022.905947. eCollection 2022. Front Pharmacol. 2022. PMID: 35734411 Free PMC article. Review.

5

Advances in pharmacokinetics and pharmacodynamics of PD-1/PD-L1 inhibitors.

Yan T, Yu L, Shangguan D, Li W, Liu N, Chen Y, Fu Y, Tang J, Liao D. Yan T, et al. Among authors: shangguan d. Int Immunopharmacol. 2023 Feb;115:109638. doi: 10.1016/j.intimp.2022.109638. Epub 2022 Dec 30. Int Immunopharmacol. 2023. PMID: 36587500 Free article. Review.

6

Immunomodulatory Therapies for Renal Cell Carcinoma.

Liu M, Wu H, Shangguan D, Jiang Y, Li X, Liu S, Zhou B, Yin T, Gong Z. Liu M, et al. Among authors: shangguan d. Protein Pept Lett. 2018;25(6):534-547. doi: 10.2174/0929866525666180531080118. Protein Pept Lett. 2018. PMID: 29848257 Review.

7

Two new triterpenoid glycosides from leaves of Cyclocarya paliurus.

Sun H, Zhu H, Wu J, Wang Y, Li G, Liu Y, Chang X, Ou S, Zha W, Chen H, Gui R, He X, Lu S, Shangguan D, Xu K. Sun H, et al. Among authors: shangguan d. Nat Prod Res. 2022 Oct;36(20):5277-5282. doi: 10.1080/14786419.2021.1931182. Epub 2021 May 25. Nat Prod Res. 2022. PMID: 34034582

8

Recent advances in immune checkpoint inhibitor-induced type 1 diabetes mellitus.

Liao D, Liu C, Chen S, Liu F, Li W, Shangguan D, Shi Y. Liao D, et al. Among authors: shangguan d. Int Immunopharmacol. 2023 Sep;122:110414. doi: 10.1016/j.intimp.2023.110414. Epub 2023 Jun 28. Int Immunopharmacol. 2023. PMID: 37390646 Free article. Review.

9

Recent Advances in the Management of Adverse Events Associated with Lorlatinib.

Liao D, Zhang J, Yan T, Chen S, Li W, Shangguan D, She Z. Liao D, et al. Among authors: shangguan d. Onco Targets Ther. 2023 Sep 5;16:731-738. doi: 10.2147/OTT.S426989. eCollection 2023. Onco Targets Ther. 2023. PMID: 37694103 Free PMC article. Review.

10

Heptamethine Cyanine-Based Molecule Release Triggered by Mitochondrial ROS.

Liu J, Yan P, Liu X, Long Z, Bing T, Zhang N, Shangguan D. Liu J, et al. Among authors: shangguan d. ACS Appl Bio Mater. 2024 Jan 15;7(1):362-368. doi: 10.1021/acsabm.3c00955. Epub 2023 Dec 27. ACS Appl Bio Mater. 2024. PMID: 38150719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

137 results

Search Page